NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Bharat Biotech's iNCOVACC: Here's how much COVID-19 nasal vaccine costs
    India

    Bharat Biotech's iNCOVACC: Here's how much COVID-19 nasal vaccine costs

    Bharat Biotech's iNCOVACC: Here's how much COVID-19 nasal vaccine costs
    Written by Manzoor-ul-Hassan
    Dec 27, 2022, 03:44 pm 3 min read
    Bharat Biotech's iNCOVACC: Here's how much COVID-19 nasal vaccine costs
    Bharat Biotech's intranasal vaccine can be used for primary two-dose schedule and also as booster shot

    Hyderabad-based vaccine maker Bharat Biotech on Tuesday announced the price of its recently-approved intranasal COVID-19 vaccine, named iNCOVACC. It is priced at Rs. 800 (excluding taxes and administration charges) for private hospitals and Rs. 325 for central/state government hospitals. The vaccine will be made available to the public in the fourth week of January. People can book their vaccination slots through the Co-WIN app.

    Why does this story matter?

    • Union Health Minister Mansukh Mandaviya informed the Parliament last week that iNCOVACC was recommended by India's technical expert committee on immunization.
    • The intranasal vaccine by Bharat Biotech received the Central Drugs Standard Control Organisation's approval (CDSCO) in September.
    • The COVAXIN manufacturer's new nasal vaccine product could help fight vaccine hesitancy and serve as a new weapon in India's arsenal against the deadly novel coronavirus.

    iNCOVACC to be available as booster for 18+

    Bharat Biotech said iNCOVACC is the world's first intranasal COVID-19 vaccine to be approved for the primary two-dose vaccine schedule and also as a heterologous booster dose. The pharma giant reportedly said it is being rolled out as a booster dose for people aged above 18. Notably, iNCOVACC showed substantial success in all three clinical trial phases and heterologous studies, per the company's release.

    Check the detailed statement by Bharat Biotech here

    iNCOVACC® is now available on CoWin.#bharatbiotech #nasalvaccine #incovacc #vaccine#covid19 #CovidVaccines #covid19vaccine #india #bbv154 #boosterdose #intranasalvaccine #safety #immunogenicity #leadinnovation #infectiousdiseases #sarscov2 #covid #health #cowin @CDSCO_INDIA_INF pic.twitter.com/IOe4YQYeh7

    — BharatBiotech (@BharatBiotech) December 27, 2022

    What did the clinical trials reveal?

    Bharat Biotech said that participants in the clinical trials showed considerable antibody levels in their saliva after receiving iNCOVACC. The company also stated that these mucosal IgA antibodies of the upper respiratory tract could help prevent infections and transmission of the virus. The pharma giant also claimed this nasal delivery method was created to be an affordable solution for low- and middle-income nations.

    Easy, painless immunization for pandemic: Dr. Krishna Ella

    Bharat Biotech's Executive Chairman, Dr. Krishna Ella, has stated, "We have achieved the goals we set for ourselves during this pandemic." "We have developed COVAXIN and iNCOVACC, two COVID-19 vaccines from two different platforms, with two different delivery systems." "The vectored intranasal delivery platform gives us the capability for rapid product development, scale-up, easy and painless immunization during public health emergencies and pandemics."

    Other vaccines available on the Co-WIN app

    Confirming the approval of "Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 (Chimpanzee Adenovirus Vectored) recombinant nasal vaccine" in September, Mandaviya termed it a "big boost" for India. Following Bharat Biotech's pricing announcement, iNCOVACC will reportedly be available for pre-booking on the Co-WIN app. Bharat Biotech's COVAXIN, Serum Institute of India's (SII) Covishield and Covovax, Russian Sputnik V, and Biological E Limited's Corbevax are currently listed on Co-WIN.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Latest
    Union Health Ministry
    COVID-19
    Bharat Biotech
    COVID-19 Vaccine

    Latest

    Defending champions GT win IPL 2023 opener versus CSK: Stats Gujarat Titans
    MS Dhoni completes 200 career IPL sixes for CSK: Stats Mahendra Singh Dhoni
    Ruturaj Gaikwad smashes 3rd-highest score in IPL season openers: Stats Ruturaj Gaikwad
    IPL 2023 opener: Chennai post 178/7 versus Gujarat Titans Chennai Super Kings (CSK)

    Union Health Ministry

    COVID-19 cases spike across India; Delhi, Maharashtra most affected COVID-19 India
    384 essential medicines to cost more from April; See list Ministry of Commerce and Industry
    India records nearly 1,900 new daily COVID-19 cases, 7 deaths COVID-19
    India records nearly 1,600 daily COVID-19 cases—highest in 5 months COVID-19

    COVID-19

    COVID-9 spike: WHO recommends additional booster shot for high-risk people World Health Organization
    UP: CM Yogi Adityanath meets Team 9 amid COVID-19 resurgence Uttar Pradesh
    World Bank president nominee Ajay Banga tests positive for COVID-19 India
    New COVID-19 variant, XBB.1.16 detected in 349 samples: Govt INSACOG

    Bharat Biotech

    India's 1st nasal COVID-19 vaccine by Bharat Biotech launched COVID-19
    COVID-19 nasal vaccines are available but should you get one?  COVID-19
    COVID-19: Centre approves Bharat Biotech's nasal vaccine as booster dose Vaccine
    Can nasal spray vaccines stop the spread of COVID-19? COVID-19

    COVID-19 Vaccine

    IIT Delhi develops new COVID-19 vaccine using immune cells COVID-19
    COVID-19: Mock drills across India to test preparedness; more updates COVID-19
    Novak Djokovic to be granted visa for Australian Open: Reports Novak Djokovic
    COVID-19 vaccination boosts cancer treatment efficacy in patients: Study Cancer

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023